Anti-CD20 Therapy Shows No Effect on Disability Progression in MS
Anti-CD20-treated primary progressive multiple sclerosis patients have higher risk for serious infection
Risk for Stroke, TIA Increased in Adults With Sickle Cell Disease
Cumulative incidence of first ischemic stroke was 2.1 percent by age 20 years, 13.5 percent by age 60 years
14.3 Million Americans Are Caring for Ill or Disabled Veteran
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions
Guidelines Provided for Diagnosis of Pediatric, Late-Onset Multiple Sclerosis
Unique biological features seen in children younger than 18 years, adults older than 50 years compared with typical adult-onset MS
Maternal Influenza Infection in Pregnancy Tied to Seizures in Offspring
Significantly increased risk for seizures and febrile convulsions, but not epilepsy, observed in offspring
Extreme Temperature-Related Deaths Set to Increase by Mid-21st Century
Greater increases projected from the current period to mid-21st century for non-Hispanic Black versus White adults
Review Compares Drug Interventions for Acute Migraine Treatment
Eletriptan most effective for pain freedom at two hours in head-to-head comparisons, followed by rizatriptan, sumatriptan, and zolmitriptan
One in Three Retired Football Players Report Perceived Chronic Traumatic Encephalopathy
Perceived chronic traumatic encephalopathy doubles risk for suicidality
Higher Burden of Comorbidity Linked to Worse Clinical Outcomes in MS
Presence of three or more comorbidities, two or more cardiometabolic comorbidities, one psychiatric disorder linked to evidence of disease activity
